KKR Nears Deal to Acquire Integer Holdings for Over $4 Billion

Private equity giant KKR is in the final stages of acquiring medical device manufacturer Integer Holdings at a valuation exceeding $4 billion. The deal is expected to close soon, continuing the trend of consolidation in the healthcare sector. Integer Holdings stands out as a supplier of components for critical medical technologies, such as cardiac and neurological devices. The company had recently become a target of an activist hedge fund with roots in Elliott Management. The fund's demands for managerial and strategic changes may have accelerated the company's sale process. According to sources, KKR's offer includes a premium over Integer's current market value. While the financial details of the deal have not yet been finalized, the parties are expected to make an official announcement in the coming days. This acquisition is seen as part of KKR's strategy to expand its investments in health technologies. Integer Holdings' shares rose following the news. Investors anticipate that the company's valuation could increase further if the deal is completed. However, processes such as regulatory approvals and shareholder consent still need to be finalized. This development indicates continued interest from private equity funds in the healthcare sector. KKR's addition of Integer to its portfolio could provide new resources to strengthen the company's R&D and manufacturing capacity. The deal is expected to be officially finalized in the coming weeks. This is not investment advice.